MesylatesErgoloid MesylatesAminationPalladiumAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantWaiting ListsCombined Modality TherapyAntineoplastic AgentsCisplatinCyclophosphamideDoxorubicinTreatment OutcomeNeoadjuvant TherapyDisease-Free SurvivalBreast NeoplasmsEtoposideNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideNeoplasmsDrug Resistance, NeoplasmBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesFollow-Up StudiesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungOvarian NeoplasmsNeoplasm MetastasisTime FactorsTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-HodgkinAntineoplastic Agents, PhytogenicRadiotherapy, AdjuvantHodgkin DiseaseColorectal NeoplasmsRadiotherapyProspective StudiesClinical Trials as TopicAntibiotics, AntineoplasticDacarbazineNeoplasms, Germ Cell and EmbryonalCarmustine